TransCelerate GCP Mutual Recognition Program

The TransCelerate GCP Mutual Recognition Program is an industry framework, run by TransCelerate BioPharma (a nonprofit collaboration of biopharmaceutical sponsor companies), under which Good Clinical Practice (GCP) training completions from a recognized training provider are accepted by multiple participating sponsor companies rather than each sponsor requiring its own separate GCP training for the same investigator or site staff member. It sits within TransCelerate's Site Qualification and Training (SQT) initiative, which targets the duplicative questionnaires, forms, and training courses that clinical trial sites have historically had to complete separately for each sponsor and, in some cases, for each individual trial. A GCP training provider participates by self-attesting that its course meets minimum criteria aligned with ICH E6 Good Clinical Practice; providers that meet the criteria have their courses made available through TransCelerate's Shared Investigator Platform (SIP), where site staff can complete training once, upload the resulting certificate, and have participating sponsors retrieve and accept it during study start-up instead of re-verifying or re-issuing training separately. A record is a genuine instance of the program when the underlying GCP course completion was issued by a provider recognized under TransCelerate's mutual-recognition criteria and is being accepted, without separate re-training, by a second (or subsequent) participating sponsor company for a different trial or company relationship -- not merely any GCP-aligned course completion in general.

ByCASRAI Editorial Board

· Last updated 18 Jul 2026

Worked examples

Is an instance

A site coordinator completes a GCP course from a provider that has self-attested to TransCelerate's mutual-recognition criteria, uploads the certificate to the Shared Investigator Platform, and a second TransCelerate member-company sponsor starting a new trial at that site accepts the existing certificate instead of requiring the coordinator to complete that sponsor's own GCP course.

Is an instance

An investigator site running concurrent trials for two different TransCelerate member companies maintains one active GCP training record on the Shared Investigator Platform that satisfies the start-up training requirement for both sponsors, rather than maintaining two separate, sponsor-specific completion records.

Looks similar, but isn't

Not an instance

A site completing a GCP course from a provider that has not self-attested to TransCelerate's mutual-recognition criteria -- the completion may still satisfy ICH E6 GCP training expectations generally, but it is not automatically recognized across TransCelerate member companies the way a program-recognized provider's course is.

Not an instance

A sponsor that is not a TransCelerate member company (or a non-participating trial relationship) requiring its own GCP training regardless of a site's existing certificate -- mutual recognition only operates among participating member companies and recognized providers, it is not a universal industry-wide GCP equivalence rule.

The TransCelerate GCP Mutual Recognition Program lets participating biopharmaceutical sponsor companies accept each other’s Good Clinical Practice (GCP) training completions for investigators and site staff, instead of each sponsor requiring the same person to repeat GCP training separately for every company and, historically, sometimes for every trial. It is run by TransCelerate BioPharma, a nonprofit collaboration of biopharmaceutical companies that develops shared, non-competitive solutions for clinical development, as part of its broader Site Qualification and Training (SQT) initiative.

SQT exists to address a specific, well-documented burden on investigator sites: clinical trial sites are routinely asked to complete duplicative questionnaires, forms, and training courses for each sponsor company they work with, which slows study start-up and adds administrative overhead that does not improve trial quality. The GCP Mutual Recognition Program is one of SQT’s core tools for reducing that burden specifically for GCP training.

How it works

The mechanism has two moving parts:

Provider self-attestation. GCP training providers can self-attest that their course content meets TransCelerate’s minimum criteria, which are aligned with ICH E6 Good Clinical Practice. TransCelerate does not itself write or deliver the training — it sets the recognition criteria that a provider’s existing course is checked against.
Distribution through the Shared Investigator Platform. Courses from providers that meet the criteria are made available through the Shared Investigator Platform (SIP), TransCelerate’s shared site-facing portal. A site staff member can complete GCP training once, upload the resulting certificate to SIP, and participating sponsor companies retrieve that certificate as part of their own study start-up activities rather than requiring a separate course.

The result is that a single GCP training completion, from a recognized provider, can satisfy the start-up training expectations of multiple TransCelerate member-company sponsors, rather than one completion per sponsor relationship.

What it solves

For investigator sites, the program is intended to cut the number of hours spent completing and re-verifying GCP training across sponsors, contributing to a more efficient trial start-up experience overall. For sponsor companies, the stated benefit is faster study start-up timelines and reduced collection of duplicate site information, since accepting an already-recognized certificate removes a step that would otherwise sit on the trial’s critical path.

Scope and limits

Mutual recognition is not a universal claim that any GCP-aligned course is interchangeable with any other. It applies specifically to: (1) courses from providers that have self-attested to TransCelerate’s criteria, and (2) acceptance among TransCelerate member companies participating in the program. A sponsor outside the program, or a training completion from a provider that has not gone through the attestation process, is not automatically covered — an individual relying institution or sponsor can still choose to accept or decline a given certificate on its own terms. This distinguishes the program from a regulatory requirement: GCP training itself is expected under ICH E6(R2) and applicable regulations, but the mutual recognition of a specific completion across companies is an industry-coordination mechanism layered on top of that expectation, not a regulatory mandate.

Other GCP training routes exist outside this program and are not automatically part of it — for example, training delivered directly by a research network for its own affiliated sites (see NIDA GCP Training) is a separate, network-specific completion pathway rather than a TransCelerate-recognized one, even where its underlying content also aligns with ICH GCP.

Related terms

Use in your systems

JATS XML <role> element

xml

<role vocab="credit"
      vocab-identifier="https://casrai.org/dictionary/"
      vocab-term="TransCelerate GCP Mutual Recognition Program"
      vocab-term-identifier="https://casrai.org/dictionary/term/transcelerate-gcp-mutual-recognition" />

Schema.org DefinedTerm (JSON-LD)

json

{
  "@context": "https://schema.org",
  "@type": "DefinedTerm",
  "@id": "https://casrai.org/dictionary/term/transcelerate-gcp-mutual-recognition",
  "name": "TransCelerate GCP Mutual Recognition Program",
  "identifier": "https://casrai.org/dictionary/term/transcelerate-gcp-mutual-recognition",
  "description": "The TransCelerate GCP Mutual Recognition Program is an industry framework, run by TransCelerate BioPharma (a nonprofit collaboration of biopharmaceutical sponsor companies), under which Good Clinical Practice (GCP) training completions from a recognized training provider are accepted by multiple participating sponsor companies rather than each sponsor requiring its own separate GCP training for the same investigator or site staff member. It sits within TransCelerate's Site Qualification and Training (SQT) initiative, which targets the duplicative questionnaires, forms, and training courses that clinical trial sites have historically had to complete separately for each sponsor and, in some cases, for each individual trial. A GCP training provider participates by self-attesting that its course meets minimum criteria aligned with ICH E6 Good Clinical Practice; providers that meet the criteria have their courses made available through TransCelerate's Shared Investigator Platform (SIP), where site staff can complete training once, upload the resulting certificate, and have participating sponsors retrieve and accept it during study start-up instead of re-verifying or re-issuing training separately. A record is a genuine instance of the program when the underlying GCP course completion was issued by a provider recognized under TransCelerate's mutual-recognition criteria and is being accepted, without separate re-training, by a second (or subsequent) participating sponsor company for a different trial or company relationship -- not merely any GCP-aligned course completion in general.",
  "inDefinedTermSet": "https://casrai.org/dictionary/domain/clinical-research#set",
  "url": "https://casrai.org/dictionary/term/transcelerate-gcp-mutual-recognition",
  "sameAs": [],
  "license": "https://creativecommons.org/licenses/by/4.0/",
  "publisher": {
    "@id": "https://casrai.org/#organization"
  },
  "dateModified": "2026-07-18T11:13:25",
  "inLanguage": "en"
}